Oracle Stock Dips Below $150 as Health Unit Bleeds Top Leaders Amid Ellison’s Struggling Bet

Several senior executives have left Oracle's health records division in recent months as the company updates its software amid significant customer losses

Oracle’s Stock Surge Highlights Investor Confidence in Cloud Strategy

Quick overview

  • Several senior executives, including Senior Vice President Suhas Uliyar and Executive Vice President Sanga Viswanathan, have recently left Oracle's health records division amid significant customer losses.
  • Oracle's stock dipped below $150 as the company updates its software following the $28 billion acquisition of Cerner Corp. in 2022.
  • The company is focusing on enhancing its cloud infrastructure and has released an AI tool aimed at improving clinical note quality and reducing burnout among users.
  • Chairman Larry Ellison remains optimistic about the potential of the health division to address industry challenges and advance medical technology.

Several senior executives have left Oracle’s health records division in recent months as the company updates its software amid significant customer losses. The stock dipped below $150 at Tuesday’s trading session.

Cloud Costs, Weak Rebound, and Mounting Skepticism Keep Oracle Subdued

Some employees were informed last week that Senior Vice President Suhas Uliyar and Executive Vice President Sanga Viswanathan were leaving the company, according to people who wished to remain anonymous because the departures hadn’t been made public.

The two were some of that division’s most senior engineering and product leaders. The $28 billion purchase of Cerner Corp., a provider of electronic medical records, created Oracle’s health division by 2022.

Chairman Larry Ellison stated that by updating infamously antiquated systems and giving Oracle, a company well-known for its database software, a significant growth engine, the deal would help address many of the industry’s problems.

Quais Taraki, Ofer Michael, and Max Romanenko are three more senior vice presidents who recently departed the unit. Before being transferred to the acquired unit to assist in its transformation, each was an executive in Oracle’s cloud infrastructure division. Taraki and Romanenko visited the database software firm EDB. In order to fulfill large AI contracts with clients like OpenAI, Oracle’s primary focus over the past year has been growing its cloud infrastructure business and constructing data centers.

Nevertheless, the business discussed its ambitious plan to advance medical technology in public. Recently, Oracle released a tool that uses AI to transcribe clinical notes.

According to a November KLAS report, early user feedback is encouraging and suggests it can help lower burnout and improve clinical note quality. One of the most ardent supporters of the agreement was Ellison, 81, a significant supporter of longevity research, who claimed it would result in a “national health records

ABOUT THE AUTHOR See More
Olumide Adesina
Financial Market Writer
Olumide Adesina is a French-born Nigerian financial writer. He tracks the financial markets with over 15 years of working experience in investment trading.

Related Articles

HFM

HFM rest

Pu Prime

XM

Best Forex Brokers